{"id":412,"date":"2025-11-03T06:56:20","date_gmt":"2025-11-03T06:56:20","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=412"},"modified":"2025-11-03T06:56:21","modified_gmt":"2025-11-03T06:56:21","slug":"china-bd-2025-transthera-and-neurocrine-enters-a-882-usd-million-license-on-nlrp3-inhibitor-program","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2025\/412.html","title":{"rendered":"[China BD 2025] TransThera and Neurocrine Enters a 882 USD Million License on NLRP3 Inhibitor Program"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Announced Date: 2025-11-03 (November 3, 2025)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensor (Seller): TransThera Sciences (China)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensee (Buyer): Neurocrine Biosciences\u00a0 (US)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Name: NLRP3 Program<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Modality: Small Molecule<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Target: NLRP3 Inhibitor <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Potential Indication: <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Current Stage: <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Scope of Authority:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neurocrine Biosciences\u00a0 will obtain exclusive rights to develop, manufacture and commercialize the NLRP3 program out of Great China.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payment Detail:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Detail Undisclosed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">TransThera Sciences will receive an upfront payment, development and sales milestone payments,  total up to 881.5 USD million and royalties based on sales revenue from Taiho.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Link:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/stockn.xueqiu.com\/02617\/20251103378892.pdf\">20251103378892.pdf (xueqiu.com)<\/a> <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Note:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Chinese Name of TransThera Sciences \u836f\u6377\u5b89\u5eb7<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2025-11-03 (November 3, 2025) Licensor (Seller): TransThera Sciences (China) Licensee (Buyer): Neurocrine Biosciences\u00a0 (US) &hellip; <a title=\"[China BD 2025] TransThera and Neurocrine Enters a 882 USD Million License on NLRP3 Inhibitor Program\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2025\/412.html\"><span class=\"screen-reader-text\">[China BD 2025] TransThera and Neurocrine Enters a 882 USD Million License on NLRP3 Inhibitor Program<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-412","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=412"}],"version-history":[{"count":1,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/412\/revisions"}],"predecessor-version":[{"id":413,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/412\/revisions\/413"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}